Inhibition of treatment-induced cell survival signalling enhances radiosensitivity of PTEN-deficient prostate cancer
Loss of the tumour suppressor PTEN is a common feature of prostate cancer (PCa) and has recently been identified as a prognostic factor for patient relapse following radiotherapy. Published studies in our laboratory have identified CXCL8 signalling as a mediator of PTEN-depleted disease progression...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.680869 |